Manage Your Liver
Q:

What is Hepatitis C?

A:

Hepatitis C is an infection caused by hepatitis C virus (HCV). This virus attacks the liver and leads to inflammation. It is generally considered to be among the most serious of hepatitis viruses. Some people who are infected with HCV will recover within six months without any treatment.


But 55–85% of those infected will develop chronic hepatitis C infection.

 

Chronic hepatitis C can lead to serious liver damage like cirrhosis or liver cancer later in life.

 

Causes

The hepatitis C virus (HCV) is transmitted through blood. The most common modes of infection are through sharing needles and unscreened blood and blood products.

 

Signs and Symptoms

  • Nausea and vomiting
  • Fatigue
  • Fever
  • Loss of appetite
  • Abdominal and/or joint pain
  • Dark urine
  • Jaundice (yellowing of skin or whites of eyes)

 

Diagnosis

The hepatitis C virus test is a blood test that looks for antibodies against the hepatitis C virus. It shows whether the patient has been exposed to the virus. Another blood test that looks for the RNA of the hepatitis C virus shows whether the patient is infected with the virus now.

 

Liver Function Test

Liver health can be monitored by regular blood tests that measures the levels of liver enzymes. About two thirds of people with chronic hepatitis C have continuously elevated ALT (GPT) levels, reflecting ongoing damage to liver cells. AST (GOT) levels are also often elevated in people with chronic hepatitis C.

 

Treatment

According to the WHO, the goal of treatment of chronic hepatitis C is cure. The current standard treatment for hepatitis C is combination antiviral therapy with these two medicines:

  • Interferon – a protein that stimulates the immune system to attack virus
  • Ribavirin – an antiviral drug that stops hepatitis C from spreading inside the body

Unfortunately, the treatment is often not successful since many patients do not finish their treatment due to strong, unbearable side effects. For those who do finish their treatment, chance of success is around 45% (genotype 1 patients) and 75% (genotype 2 or 3 patients).

 

Side Effects

Interferon or ribavirin can have side effects such as fatigue, flu-like symptoms, anemia, insomnia, depression, nausea and diarrhea.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
Hep CHepatitis CHCV
Related Questions
A:
In our last post, we brought up the recent findings on extreme liver cancer growth after successful DAA treatment. We are talking about liver cancer of a few centimetres developed within weeks of successful Hep C treatment. These findings are also observed in patients of Gastroenterology. Dr. Roushdi Khalf allah sai
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
Hit Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Have
Questions?
Sumbit your question
to us for profeessional answers!
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Looking for help? Ask our customer support team!
Contact Us